Pathogenesis and Prevention of Worsening Axial Elongation in Pathological Myopia
- PMID: 32256044
- PMCID: PMC7092688
- DOI: 10.2147/OPTH.S241435
Pathogenesis and Prevention of Worsening Axial Elongation in Pathological Myopia
Abstract
Purpose: This review discusses the etiology and pathogenesis of myopia, prevention of disease progression and worsening axial elongation, and emerging myopia treatment modalities.
Introduction: Pediatric myopia is a public health concern that impacts young children worldwide and is associated with numerous future ocular diseases such as cataract, glaucoma, retinal detachment and other chorioretinal abnormalities. While the exact mechanism of myopia of the human eye remains obscure, several studies have reported on the role of environmental and genetic factors in the disease development.
Methods: A review of literature was conducted. PubMed and Medline were searched for combinations and derivatives of the keywords including, but not limited to, "pediatric myopia", "axial elongation", "scleral remodeling" or "atropine." The PubMed and Medline database search were performed for randomized control trials, systematic reviews and meta-analyses using the same keyword combinations.
Results: Studies have reported that detection of genetic correlations and modification of environmental influences may have a significant impact in myopia progression, axial elongation and future myopic ocular complications. The conventional pharmacotherapy of pediatric myopia addresses the improvement in visual acuity and prevention of amblyopia but does not affect axial elongation or myopia progression. Several studies have published varying treatments, including optical, pharmacological and surgical management, which show great promise for a more precise control of myopia and preservation of ocular health.
Discussion: Understanding the role of factors influencing the onset and progression of pediatric myopia will facilitate the development of successful treatments, reduction of disease burden, arrest of progression and improvement in future of the management of myopia.
Keywords: atropine in the treatment of myopia (ATOM) study; axial elongation; macular buckle; myopia maculopathies; myopic foveoschisis; pediatric myopia; scleral remodeling.
© 2020 Pugazhendhi et al.
Conflict of interest statement
Dr Balamurali Ambati reports a pending patent PCT/US2019/012501. The authors report no other conflicts of interest in this work.
Similar articles
-
Interventions to slow progression of myopia in children.Cochrane Database Syst Rev. 2020 Jan 13;1(1):CD004916. doi: 10.1002/14651858.CD004916.pub4. Cochrane Database Syst Rev. 2020. PMID: 31930781 Free PMC article.
-
Treatment effect of posterior scleral reinforcement on controlling myopia progression: A systematic review and meta-analysis.PLoS One. 2020 May 26;15(5):e0233564. doi: 10.1371/journal.pone.0233564. eCollection 2020. PLoS One. 2020. PMID: 32453804 Free PMC article.
-
Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.JAMA Ophthalmol. 2020 Nov 1;138(11):1178-1184. doi: 10.1001/jamaophthalmol.2020.3820. JAMA Ophthalmol. 2020. PMID: 33001210 Free PMC article. Clinical Trial.
-
Outcomes of macular buckling with a T-shaped buckle for myopic tractional maculopathies associated with posterior staphyloma: An Indian experience.Indian J Ophthalmol. 2022 Jan;70(1):171-179. doi: 10.4103/ijo.IJO_3720_20. Indian J Ophthalmol. 2022. PMID: 34937231 Free PMC article.
-
An examination of the baropathic nature of axial myopia.Clin Exp Optom. 2014 Mar;97(2):116-24. doi: 10.1111/cxo.12101. Epub 2013 Aug 13. Clin Exp Optom. 2014. PMID: 23937058 Review.
Cited by
-
Dioptric power and refractive behaviour: a review of methods and applications.BMJ Open Ophthalmol. 2022 Apr 1;7(1):e000929. doi: 10.1136/bmjophth-2021-000929. eCollection 2022. BMJ Open Ophthalmol. 2022. PMID: 35452207 Free PMC article. Review.
-
Microvascular Alterations of Peripapillary Choriocapillaris in Young Adult High Myopia Detected by Optical Coherence Tomography Angiography.J Pers Med. 2023 Feb 4;13(2):289. doi: 10.3390/jpm13020289. J Pers Med. 2023. PMID: 36836523 Free PMC article.
-
Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS).Br J Ophthalmol. 2023 Nov;107(11):1709-1715. doi: 10.1136/bjo-2021-321005. Epub 2022 Sep 1. Br J Ophthalmol. 2023. PMID: 36126105 Free PMC article. Clinical Trial.
-
Retardation of myopia by atropine regimes.Int J Ophthalmol. 2024 Nov 18;17(11):2129-2140. doi: 10.18240/ijo.2024.11.20. eCollection 2024. Int J Ophthalmol. 2024. PMID: 39559301 Free PMC article. Review.
-
Efficacy of spectacle lenses specifically designed for myopia control: systematic review and meta-analysis.Graefes Arch Clin Exp Ophthalmol. 2025 Apr;263(4):909-924. doi: 10.1007/s00417-024-06706-4. Epub 2024 Dec 9. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 39652182
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources